ADMA ADMA Biologics, Inc.
$10.18 +0.69%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.69%
YTD
-27.20%
P/E
13.16
P/B
9.09
ROE
39.6%
Div yield
—
Beta
0.8
Market cap
$2.2B
RSI (14)
60
Next earnings
Nov 3, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$10.20
Close
$10.18
VWAP (n/a)
—
Day high
$10.35
Day low
$9.98
Volume
2.1M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
ADMA Biologics (ADMA), Why Is It Back In The Spotlight?
Yahoo Finance · Sep 27
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today
Yahoo Finance · Sep 24
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
Yahoo Finance · Sep 24
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance · Sep 18
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
Yahoo Finance · Sep 11
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know
Yahoo Finance · Sep 10
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Aug 5, 2026 View → 8-K Jun 2, 2026 View → 10-Q May 6, 2026 View → 8-K May 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ADMA. Try it in the Lab to size a position and see the risk.